MedTrace Logo

A Comparison of Collagen, Lidocaine and Saline, in Trigger Points in Masseter Muscle.

NCT03323567 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2018-01-04

No results posted yet for this study

Summary

An intramusclular injection of three solutions were performed( collagen, lidocaine, saline) in musculoskeletal trigger points, in patients suffering from temporomandibular disorders(TMD). Best results were observed in collagen group: reduction of 59,2% sEMG activity of masseter muscles and 53,75% reduction of pain intensity in VAS scale.

Conditions

  • Temporomandibular Disorder

Interventions

DRUG

MD Muscle GUNA collagen

intramusclular injections of MD Muscle collagen

DRUG

Lidocaine 2% Injectable Solution

intramuscular Lidocaine 2% injection

DRUG

Saline Solution, Hypertonic

intramuscular Saline injection

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-10
Primary Completion
2017-10-04
Completion
2017-10-12

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03323567 on ClinicalTrials.gov